-
1
-
-
84859555815
-
Vorapaxar in the secondary prevention of atherothrombotic events
-
TRA 2P-TIMI 50 Steering Committee and Investigators
-
D.A. Morrow, E. Braunwald, M.P. Bonaca TRA 2P-TIMI 50 Steering Committee and Investigators Vorapaxar in the secondary prevention of atherothrombotic events N Engl J Med 366 2012 1404 1413
-
(2012)
N Engl J Med
, vol.366
, pp. 1404-1413
-
-
Morrow, D.A.1
Braunwald, E.2
Bonaca, M.P.3
-
2
-
-
84876282305
-
Efficacy and safety of vorapaxar in patients with prior ischemic stroke
-
Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Steering Committee and Investigators
-
D.A. Morrow, M.J. Alberts, J.P. Mohr Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Steering Committee and Investigators Efficacy and safety of vorapaxar in patients with prior ischemic stroke Stroke 44 2013 691 698
-
(2013)
Stroke
, vol.44
, pp. 691-698
-
-
Morrow, D.A.1
Alberts, M.J.2
Mohr, J.P.3
-
3
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
TRITON-TIMI 38 Investigators
-
S.D. Wiviott, E. Braunwald, C.H. McCabe TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
-
4
-
-
51449116270
-
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
-
PRoFESS Study Group
-
R.L. Sacco, H.C. Diener, S. Yusuf PRoFESS Study Group Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke N Engl J Med 359 2008 1238 1251
-
(2008)
N Engl J Med
, vol.359
, pp. 1238-1251
-
-
Sacco, R.L.1
Diener, H.C.2
Yusuf, S.3
-
5
-
-
33645737200
-
Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline
-
American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention: American Academy of Neurology
-
R.L. Sacco, R. Adams, G. Albers American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention: American Academy of Neurology Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline Circulation 113 2006 e409 e449
-
(2006)
Circulation
, vol.113
, pp. 409-e449
-
-
Sacco, R.L.1
Adams, R.2
Albers, G.3
-
6
-
-
84865485153
-
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
-
SPS3 Investigators
-
SPS3 Investigators O.R. Benavente, R.G. Hart, and L.A. McClure Effects of clopidogrel added to aspirin in patients with recent lacunar stroke N Engl J Med 367 2012 817 825
-
(2012)
N Engl J Med
, vol.367
, pp. 817-825
-
-
Benavente, O.R.1
Hart, R.G.2
McClure, L.A.3
-
7
-
-
3242770664
-
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial
-
H.C. Diener, J. Bogousslavsky, and L.M. Brass Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial Lancet 364 2004 331 337
-
(2004)
Lancet
, vol.364
, pp. 331-337
-
-
Diener, H.C.1
Bogousslavsky, J.2
Brass, L.M.3
-
8
-
-
84876295389
-
Clopidogrel added to aspirin adds no benefit but bleeding risk in patients with recent lacunar stroke
-
H.C. Diener, and R. Weber Clopidogrel added to aspirin adds no benefit but bleeding risk in patients with recent lacunar stroke Stroke 44 2013 861 863
-
(2013)
Stroke
, vol.44
, pp. 861-863
-
-
Diener, H.C.1
Weber, R.2
-
10
-
-
34548201725
-
Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States
-
D.Q. Rich, J.M. Gaziano, and T. Kurth Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States Stroke 38 2007 2221 2227
-
(2007)
Stroke
, vol.38
, pp. 2221-2227
-
-
Rich, D.Q.1
Gaziano, J.M.2
Kurth, T.3
-
11
-
-
84855353573
-
Heart disease and stroke statistics - 2012 update: A report from the American Heart Association
-
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
V.L. Roger, A.S. Go, D.M. Lloyd-Jones American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
-
(2012)
Circulation
, vol.125
, pp. 2-e220
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
-
12
-
-
68949156886
-
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the thrombin-receptor antagonist in secondary prevention of atherothrombotic ischemic events (TRA 2°P)-TIMI 50 trial
-
TRA 2°P-TIMI 50 Investigators
-
D.A. Morrow, B.M. Scirica, K.A. Fox TRA 2°P-TIMI 50 Investigators Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the thrombin-receptor antagonist in secondary prevention of atherothrombotic ischemic events (TRA 2°P)-TIMI 50 trial Am Heart J 158 2009 335 341.e3
-
(2009)
Am Heart J
, vol.158
, pp. 335-341e3
-
-
Morrow, D.A.1
Scirica, B.M.2
Fox, K.A.3
-
13
-
-
84867336413
-
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: A prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
-
TRA 2°P-TIMI 50 Steering Committee Investigators
-
B.M. Scirica, M.P. Bonaca, E. Braunwald TRA 2°P-TIMI 50 Steering Committee Investigators Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial Lancet 380 2012 1317 1324
-
(2012)
Lancet
, vol.380
, pp. 1317-1324
-
-
Scirica, B.M.1
Bonaca, M.P.2
Braunwald, E.3
-
14
-
-
0023889706
-
Interobserver agreement for the assessment of handicap in stroke patients
-
J.C. van Swieten, P.J. Koudstaal, and M.C. Visser Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 1988 604 607
-
(1988)
Stroke
, vol.19
, pp. 604-607
-
-
Van Swieten, J.C.1
Koudstaal, P.J.2
Visser, M.C.3
-
15
-
-
44449107747
-
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
-
American Heart Association; American Stroke Association
-
R.J. Adams, G. Albers, M.J. Alberts American Heart Association; American Stroke Association Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack Stroke 39 2008 1647 1652
-
(2008)
Stroke
, vol.39
, pp. 1647-1652
-
-
Adams, R.J.1
Albers, G.2
Alberts, M.J.3
-
17
-
-
77955014011
-
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study
-
INTERSTROKE Investigators
-
M.J. O'Donnell, D. Xavier, L. Liu INTERSTROKE Investigators Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study Lancet 376 2010 112 123
-
(2010)
Lancet
, vol.376
, pp. 112-123
-
-
O'Donnell, M.J.1
Xavier, D.2
Liu, L.3
-
18
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
19
-
-
65849268320
-
Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
-
Antithrombotic Trialists' (ATT) Collaboration C. Baigent, L. Blackwell, and R. Collins Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
-
(2009)
Lancet
, vol.373
, pp. 1849-1860
-
-
Baigent, C.1
Blackwell, L.2
Collins, R.3
-
20
-
-
0030590746
-
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
-
CAPRIE Steering Committee
-
CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
-
(1996)
Lancet
, vol.348
, pp. 1329-1339
-
-
-
21
-
-
84879775488
-
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack
-
CHANCE Investigators
-
Y. Wang, Y. Wang, X. Zhao CHANCE Investigators Clopidogrel with aspirin in acute minor stroke or transient ischemic attack N Engl J Med 369 2013 11 19
-
(2013)
N Engl J Med
, vol.369
, pp. 11-19
-
-
Wang, Y.1
Wang, Y.2
Zhao, X.3
|